Biotech Publicity
The Forbes magazine supplement ASAP
Cancer
Biomira, Alberta, Canada; founded 1985; www.biomira.com; 1998 revenues: $3.9M; projected 1999 revenues: $1.3M
Biomira's vaccine for breast cancer, Theratope, is in Phase III clinical trials. Chiron has marketing and distribution rights. Biomira also sold off its diagnostics division to focus more on vaccines.
Corixa, Seattle, WA; founded 1994; www.corixa. com; 1998 revenues: $18.3M; projected 1999 revenues: $24.5M
The leading company for the development of antigens, Corixa maintains partnerships with SmithKline Beecham and PMC.
Progenics Pharmaceuticals, Tarrytown, NY; founded 1988; www.
progenics.com; 1998 revenues: $14M; projected 1999 revenues: $23M
Under a partnership with Bristol-Myers Squibb, Progenics has the first antigen-specific vaccine ever in Phase III clinical trials. It will treat malignant melanoma. |
